Medmira Stock Market Value
| MMIRF Stock | USD 0.06 0.00 0.00% |
| Symbol | MedMira |
MedMira 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MedMira's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MedMira.
| 12/04/2022 |
| 11/23/2024 |
If you would invest 0.00 in MedMira on December 4, 2022 and sell it all today you would earn a total of 0.00 from holding MedMira or generate 0.0% return on investment in MedMira over 720 days. MedMira is related to or competes with Pharming Group. MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and tech... More
MedMira Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MedMira's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MedMira upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1227 | |||
| Maximum Drawdown | 321.49 | |||
| Value At Risk | (0.17) | |||
| Potential Upside | 0.7692 |
MedMira Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MedMira's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MedMira's standard deviation. In reality, there are many statistical measures that can use MedMira historical prices to predict the future MedMira's volatility.| Risk Adjusted Performance | 0.1065 | |||
| Jensen Alpha | 5.55 | |||
| Total Risk Alpha | (1.22) | |||
| Treynor Ratio | (0.86) |
MedMira Backtested Returns
MedMira is out of control given 3 months investment horizon. MedMira has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We were able to interpolate data for nineteen different technical indicators, which can help you to evaluate if expected returns of 5.02% are justified by taking the suggested risk. Use MedMira Standard Deviation of 38.67, risk adjusted performance of 0.1065, and Mean Deviation of 9.7 to evaluate company specific risk that cannot be diversified away. MedMira holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -5.67, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning MedMira are expected to decrease by larger amounts. On the other hand, during market turmoil, MedMira is expected to outperform it. Use MedMira information ratio, as well as the relationship between the potential upside and day median price , to analyze future returns on MedMira.
Auto-correlation | 0.09 |
Virtually no predictability
MedMira has virtually no predictability. Overlapping area represents the amount of predictability between MedMira time series from 4th of December 2022 to 29th of November 2023 and 29th of November 2023 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MedMira price movement. The serial correlation of 0.09 indicates that less than 9.0% of current MedMira price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
MedMira lagged returns against current returns
Autocorrelation, which is MedMira pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MedMira's pink sheet expected returns. We can calculate the autocorrelation of MedMira returns to help us make a trade decision. For example, suppose you find that MedMira has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MedMira regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MedMira pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MedMira pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MedMira pink sheet over time.
Current vs Lagged Prices |
| Timeline |
MedMira Lagged Returns
When evaluating MedMira's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MedMira pink sheet have on its future price. MedMira autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MedMira autocorrelation shows the relationship between MedMira pink sheet current value and its past values and can show if there is a momentum factor associated with investing in MedMira.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in MedMira Pink Sheet
MedMira financial ratios help investors to determine whether MedMira Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedMira with respect to the benefits of owning MedMira security.